These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 7530624)
1. Trough/peak ratios for antihypertensive agents. The issues in perspective. Meredith PA Drugs; 1994 Nov; 48(5):662-6. PubMed ID: 7530624 [No Abstract] [Full Text] [Related]
2. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration. Meredith PA; Elliott HL J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S26-30. PubMed ID: 7609502 [TBL] [Abstract][Full Text] [Related]
3. Trough to peak ratio: current status and applicability. Elliott HL J Hum Hypertens; 1998 Jan; 12(1):55-9. PubMed ID: 9482135 [No Abstract] [Full Text] [Related]
4. Practical relevance of the 24-hour trough: peak ratio of antihypertensive drugs. Zannad F J Hypertens Suppl; 1995 Aug; 13(2):S109-12. PubMed ID: 8576780 [TBL] [Abstract][Full Text] [Related]
5. Problems in the evaluation of antihypertensive therapy using the trough/peak ratio. Prattichizzo FA; Galetta F; Simonetti I Cardiovasc Drugs Ther; 1997 Jul; 11(3):459-63. PubMed ID: 9310274 [TBL] [Abstract][Full Text] [Related]
6. Trough: peak ratio: the rationale behind the United States Food and Drug Administration recommendations. Lipicky RJ J Hypertens Suppl; 1994 Nov; 12(8):S17-8; discussion S18-9. PubMed ID: 7707150 [TBL] [Abstract][Full Text] [Related]
7. Shortcomings in the trough to peak ratio as a guide to the dose interval for antihypertensive drugs. Millar JA J Hum Hypertens; 1998 Jan; 12(1):37-44. PubMed ID: 9482132 [No Abstract] [Full Text] [Related]
8. Role of trough to peak efficacy in the evaluation of antihypertensive therapy. Meredith PA J Hypertens Suppl; 1998 Jan; 16(1):S59-64. PubMed ID: 9534099 [TBL] [Abstract][Full Text] [Related]
9. Trough to peak ratio as a guide to BP control: measurement and calculation. Morgan T; Ménard J; Brunner H J Hum Hypertens; 1998 Jan; 12(1):49-53. PubMed ID: 9482134 [No Abstract] [Full Text] [Related]
11. Trough: peak ratio and smoothness index for antihypertensive agents. Meredith PA Blood Press Monit; 1999 Oct; 4(5):257-62. PubMed ID: 10547647 [TBL] [Abstract][Full Text] [Related]
12. Trough to peak ratio: time for reappraisal? Millar JA J Hum Hypertens; 1998 Jan; 12(1):35-6. PubMed ID: 9482131 [No Abstract] [Full Text] [Related]
13. Some problems with antihypertensive drug studies in the context of the new guidelines. Rose M; McMahon FG Am J Hypertens; 1990 Feb; 3(2):151-5. PubMed ID: 2407266 [TBL] [Abstract][Full Text] [Related]
14. Twenty-four hour blood pressure control and trough to peak ratio: who, when, how and why? Morgan T; Ménard J; Brunner H J Hum Hypertens; 1998 Jan; 12(1):45-8. PubMed ID: 9482133 [No Abstract] [Full Text] [Related]
15. [Problems in evaluating the long-term effect of antihypertensive drugs: once again: the trough/peak ratio]. Hitzenberger G Wien Med Wochenschr; 1997; 147(14):333-5. PubMed ID: 9381727 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect of drugs: statistical distribution of the trough-to-peak ratio. Chi VX; Chau NP Biometrics; 1996 Mar; 52(1):286-90. PubMed ID: 8934597 [TBL] [Abstract][Full Text] [Related]
17. [Current views on the treatment of borderline and mild hypertension]. Czarniecki W Pol Arch Med Wewn; 1988; 80(2-3):156-61. PubMed ID: 3078206 [No Abstract] [Full Text] [Related]
18. [New treatments in hypertension: direct renin inhibitors]. Leibovitz E; Schiffrin EL Harefuah; 2008 Mar; 147(3):218-23, 278. PubMed ID: 18488863 [TBL] [Abstract][Full Text] [Related]
19. Methodology to determine duration of action for antihypertensive drugs. Lefebvre J; Poirier L; Lacourcière Y Ann Pharmacother; 2002 May; 36(5):874-81. PubMed ID: 11978167 [TBL] [Abstract][Full Text] [Related]